Welcome to our dedicated page for Docusign SEC filings (Ticker: DOCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for Docusign, Inc. (NASDAQ: DOCU), a software company focused on digital agreements, eSignature, and Intelligent Agreement Management (IAM). Through these filings, investors can review the company’s official disclosures on financial performance, risk factors, governance, and key business developments.
Annual reports on Form 10-K typically include detailed discussions of DocuSign’s business, including its IAM platform, eSignature and contract lifecycle management offerings, customer base, and the risks and opportunities associated with its operations. Quarterly reports on Form 10-Q provide interim financial statements, management’s discussion and analysis, and updates on metrics such as revenue, subscription trends, billings, and cash flows.
Current reports on Form 8-K disclose material events, such as quarterly financial results and certain corporate governance changes. For example, DocuSign has used Form 8-K to report financial results for specific quarters and to announce board appointments and leadership roles. These filings help investors track significant developments between regular reporting periods.
Other filings, such as proxy statements and any Form 4 insider transaction reports, can offer additional insight into executive and director compensation, equity awards, and share ownership, as well as governance practices. Together, these documents form the regulatory record of DOCU as a Nasdaq-listed issuer.
On Stock Titan, SEC filings for DOCU are updated from the EDGAR system, and AI-powered summaries can assist readers by highlighting key points from lengthy documents like 10-Ks and 10-Qs. This can help users quickly understand DocuSign’s reported results, non-GAAP metrics, and material events without reading every page of each filing.
Irving Blake, a director of DocuSign, Inc. (DOCU), reported purchases and a grant on Form 4. On 08/29/2025 Mr. Blake acquired 729 shares of common stock at no cash price (Transaction Code M), bringing his total direct beneficial ownership to 23,906 shares. He also received a grant of 729 Restricted Stock Units (RSUs) that vest quarterly over one year beginning May 29, 2025, with the final installment accelerated to the earlier of the next annual meeting or the one-year anniversary. The RSUs do not expire and convert one-for-one into common shares upon vesting. The filing was signed by an attorney-in-fact on 09/02/2025.
Form 4 filing by Peter Solvik, a director at DocuSign (DOCU), reports receipt of equity awards and current beneficial ownership. The filing shows a grant of 729 restricted stock units (RSUs) on 08/29/2025 under transaction code M, with a reported acquisition price of $0. The RSUs convert one-for-one into common shares and are reflected as 729 underlying shares held directly following the transaction.
The filing also discloses other holdings: 6,783 shares directly, 150,253 shares held by a trust, 65,558 by children’s trusts, 3 by a family partnership, and 6,458 by spouse. The RSUs have a May 29, 2025 vest commencement date and vest quarterly over one year, with specific acceleration language for the fourth installment.
DocuSign director James A. Beer received a grant of 729 Restricted Stock Units (RSUs) on 08/29/2025. Each RSU converts to one share of DocuSign common stock and was granted at a $0 purchase price. The filing shows the Reporting Person beneficially owns 14,649 shares directly and 5,543 shares indirectly (by trust) after the reported transactions, and holds 2,187 shares underlying RSUs following the grant. The RSUs have a vest commencement date of 05/29/2025 and vest in equal quarterly installments over one year, with the final installment subject to earlier vesting tied to the company’s next annual meeting or the one-year anniversary. The RSUs do not expire and are canceled if they fail to vest.
DocuSign, Inc. (DOCU) filed a Form 144 disclosing that the Daniel Springer Revocable Trust, identified as a former affiliate, plans to sell up to 66,882 common shares on or about 26 June 2025. The shares will be sold through Morgan Stanley Smith Barney LLC on the Nasdaq exchange. At the 4 June 2025 market price implied by the filing, the transaction represents an aggregate market value of approximately US$5.04 million, equating to an implied price of roughly US$75.31 per share.
The proposed sale represents less than 0.04 % of DocuSign’s 202,062,772 shares outstanding, indicating limited dilution or market overhang risk. The securities were originally acquired via open-market purchase on 15 March 2022 and were fully paid for in cash. The filer reported no other sales in the past three months and affirmed that no undisclosed material adverse information is known.
Form 144 filings are routinely used by insiders and affiliates to notify the SEC of intended Rule 144 sales and do not obligate the seller to complete the transaction. Nevertheless, investors often monitor such filings as indicators of insider sentiment, even when the dollar amount is modest relative to the company’s market capitalization.
FAQ
What is the current stock price of Docusign (DOCU)?
What is the market cap of Docusign (DOCU)?
